Helper gene control
AssigneeSynplogen Co., Ltd.
InventorsYuya NISHIMURA, Shunsuke SAITO
Life of this patent
Estimating the term…
Loading patent…
AssigneeSynplogen Co., Ltd.
InventorsYuya NISHIMURA, Shunsuke SAITO
Estimating the term…
The present disclosure provides control of expression of a Rep gene by control of expression of a helper gene. In one aspect, the present disclosure provides a method for controlling the expression of a Rep gene, including a step of controlling the expression of a helper gene. In one embodiment, the helper gene includes a gene selected from adenovirus E1B, E2, E4 and VA. In one embodiment, the helper gene includes an adenovirus E1B gene. In one embodiment, the helper gene includes two or more helper genes related to the production of an adeno-associated virus (AAV)-derived construct, and optionally, the helper genes can be selected from E1A, E1B, E2, E4, and VA. In one embodiment, the helper gene includes a helper gene selected from E1A and E1B and a helper gene selected from E2, E4 and VA.
A method for controlling expression of a Rep gene, comprising a step of controlling expression of a helper gene selected from E1B, E2, E4 and VA.
A method for controlling expression of a Rep gene, comprising a step of controlling expression of an E1B helper gene.
A method for controlling expression of a Rep gene, comprising a step of controlling expression of two or more helper genes related to production of an adeno-associated virus (AAV)-derived construct.
A combination for controlling expression of a Rep gene, comprising:
A combination for controlling expression of a Rep gene, comprising:
Dependencies are inferred from the claim text.